Literature DB >> 19717724

Model-based evaluation of QTc interval risk: an increasing emphasis on early decision making.

Rajesh Krishna.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19717724     DOI： 10.1177/0091270009344086

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  2 in total

Review 1.  The role of concentration-effect relationships in the assessment of QTc interval prolongation.

Authors:  Nicholas P France; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

2.  Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects.

Authors:  Rajesh Krishna; Carol Addy; Daniel Tatosian; Xiaoli S Glasgow; Isaias Noel Gendrano Iii; Martine Robberechts; Wouter Haazen; J N de Hoon; Marleen Depré; Ashley Martucci; Joanna Z Peng; Amy O Johnson-Levonas; John A Wagner; S Aubrey Stoch
Journal:  J Clin Pharmacol       Date:  2016-06-17       Impact factor: 3.126
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.